Chinese expert guidance on critical care hemoadsorption (2025)
Year: 2025
Type: article
Abstract: Hemoadsorption (HA) has become an important adjunctive therapy in critical care, with potential benefits in managing sepsis, severe acute pancreatitis (SAP), poisoning, and rhabdomyolysis (RM). However, significant heterogeneity in clinical evidence, the diversity of adsorption devices, and lack of standardized protocols hinder its widespread and rational use. To address these issues, the Critical Care Nephrology Quality Control Subcommittee of the National Center for Healthcare Quality Management in Critical Care Medicine convened a multidisciplinary expert panel to develop a national consensus. This expert consensus summarizes current evidence, defines core concepts, categorizes HA materials and modes, and outlines indications, timing, operational procedures, anticoagulation strategies, and safety considerations. It also provides expert recommendations for the use of HA in various clinical scenarios based on collective clinical experience and literature review. The aim is to promote standardized, safe, and effective HA practices across critical care settings in China.
Authors: Changsong Wang, Songqiao Liu, Yue Zheng, Zimeng Liu, Jiao Liu, Bo Hu, Lu Ke, Jiannan Zhang, Songgen Jin, Kai Yu, Yao Nie, Sheng Zhang, Qi Zhang, Longxiang Cao, Lanting Wang
Institutions: First Affiliated Hospital of Harbin Medical University, Zhongda Hospital Southeast University, The First People’s Hospital of Lianyungang, Capital Medical University, Beijing Chao-Yang Hospital, Capital Medical University, The First Affiliated Hospital, Sun Yat-sen University, Shanghai Jiao Tong University, Ruijin Hospital, Zhongnan Hospital of Wuhan University, Nanjing General Hospital of Nanjing Military Command, Nanjing University
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W7128213278